Results 91 to 100 of about 4,977 (213)

PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION

Фармакоэкономика, 2016
The purpose of this study was to conduct the analysis of the structure and the rationality of cost in particular of providing preferential medicines patients with сhronic obstructive pulmonary disease (COPD) in Krasnoyarsk region.Materials and methods ...
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva   +5 more
doaj   +1 more source

Age-dependent elastin degradation is enhanced in chronic obstructive pulmonary disease [PDF]

, 2016
Chronic obstructive pulmonary disease (COPD) is primarily a lung condition characterised by the presence of persistent airflow limitation resulting from inflammation, remodelling of small airways, and emphysema.
, Bolton, Charlotte E., Huang, Jeffrey T. J., MacNee, William, Miller, Bruce E., Palmer, Colin N. A., Rabinovich, Roberto A., Tal-Singer, Ruth, Thomson, Neil C.   +8 more
core   +3 more sources

Safety, tolerability and risk benefit analysis of tiotropium in COPD

International Journal of COPD, 2008
Yuji Oba, Tareq Zaza, Danish M ThameemUniversity of Missouri, School of Medicine, Division of Pulmonary, Critical Care and Environmental Medicine, Columbia, MO, USAAbstract: COPD is a chronic disease and, like many other chronic diseases, there is no ...
Yuji Oba, Tareq Zaza, Danish M Thameem
doaj  

Effects of adding Tiotropium or Aclidinium as triple therapy using impulse oscillometry in COPD [PDF]

, 2016
INTRODUCTION: Long-acting muscarinic antagonists confer improvements in spirometry when used in addition to inhaled corticosteroids and long-acting beta-agonists (ICS/LABA) in COPD.
A Gavalda, AE Holland, Arvind Manoharan, Ashley E. Morrison, Brian J. Lipworth, C Crim, D Singh, J Beier, J Vestbo, KS Jung, M Cazzola, M Cazzola, MA Puhan, NA Hanania, PA Frith, PA Williamson, PA Williamson, PM Short, R Fuhr, SD Aaron, T Welte, TJ Witek Jr, WJ Anderson   +22 more
core   +3 more sources

Tiotropium Bromide Improves Neutrophilic Asthma by Recovering Histone Deacetylase 2 Activity. [PDF]

J Korean Med Sci, 2023
An TJ, Kim JH, Hur J, Park CK, Lim JU, Kim S, Rhee CK, Yoon HK.   +7 more
europepmc   +1 more source

Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities [PDF]

, 2017
Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease and its prevalence is increasing worldwide, in both industrialised and developing countries.
Brunori, G., Corrao, S., Lupo, U., Perticone, F.   +3 more
core   +2 more sources

Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations

Therapeutics and Clinical Risk Management, 2016
Ching Kuo Tan, Gui Quan Say, James B Geake Department of Respiratory Medicine, Lyell McEwin Hospital, Elizabeth Vale, SA, Australia Abstract: Tiotropium bromide is a long-acting inhaled muscarinic antagonist used in patients with chronic respiratory ...
Tan CK, Say GQ, Geake JB
doaj  

Anticholinergic therapy for acute asthma in children. [PDF]

, 2012
Inhaled anticholinergics as single agent bronchodilators (or in combination with beta(2)-agonists) are one of the several medications available for the treatment of acute asthma in ...
Beakes, Beck, Benito Fernandez, Bever, Bratteby, British Thoracic Society, Brown, Browne, Calvo, Cook, Craven, Cugell, DeStefano, Ducharme, Everard, Goggin, Gross, Guill, Hayday, Iramain, Lew, Lin, Lung, Mallol, McDonald, Mirsadraee, National Asthma Council Australia, Ni, Plotnick, Pulejo, Quereshi, Qureshi, Rayner, Reisman, Rodrigo, Schuh, Sienra Monge, Storms, Storr, Tal, Timsit, Ulrik, Undem, Wade, Ward, Ward, Yeung, Youngchaiyud, Zimmerman, Zorc   +49 more
core   +2 more sources

Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study [PDF]

, 2007
BACKGROUND: Clinical trials of tiotropium have principally recruited patients from secondary care with more severe chronic obstructive pulmonary disease (COPD), and typically had included limitation of concomitant medication.
Angela Lee, Daryl Freeman, David Price
core   +2 more sources

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice

Медицинский совет, 2019
Today, chronic obstructive pulmonary disease is the fourth global cause of deaths worldwide. A number of studies showed that 11 to 16 million people might suffer from the chronic obstructive pulmonary disease in Russia.
Р. A. Balunov, A. N. Khitrov
doaj   +1 more source